Weifeng Xu

3.7k total citations · 1 hit paper
33 papers, 1.9k citations indexed

About

Weifeng Xu is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Weifeng Xu has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Weifeng Xu's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Immune Cell Function and Interaction (10 papers) and Biosimilars and Bioanalytical Methods (10 papers). Weifeng Xu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Immune Cell Function and Interaction (10 papers) and Biosimilars and Bioanalytical Methods (10 papers). Weifeng Xu collaborates with scholars based in United States, China and Germany. Weifeng Xu's co-authors include Andrea Cerutti, April Chiu, Paul A Santini, Daniel M. Knowles, Bing He, Amy Chadburn, Meimei Shan, Alessandro Plebani, Vincenzo Villanacci and Alexandros D. Polydorides and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Immunity.

In The Last Decade

Weifeng Xu

31 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL

2007 566 citations Bing He, Weifeng Xu et al. Immunity profile →

Peers

Countries citing papers authored by Weifeng Xu

Since Specialization

Citations

This map shows the geographic impact of Weifeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Xu more than expected).

Fields of papers citing papers by Weifeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Xu. The network helps show where Weifeng Xu may publish in the future.

Co-authorship network of co-authors of Weifeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Xu. A scholar is included among the top collaborators of Weifeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Xu. Weifeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116 2025 ·Communications Medicine ·Jianing Li, Heather Platt, Wen‐Yu Hu, Weifeng Xu, Timothy J. Chapman, Katrina M. Nolan, Jonathan Hartzel, Ulrike K. Buchwald	1
2	Structure-activity relationship study of Pseudellone C as anti-glioma agents by targeting TNF/TNFR signaling pathway 2024 ·European Journal of Medicinal Chemistry ·(unknown), Weifeng Xu, Jiangnan Hu, Yong Dong, Ren‐Bo Ding, (unknown), Zhendong Zhao, (unknown), (unknown), Shuai Dong	0
3	Development and Validation of a Cell-Based Binding Neutralizing Antibody Assay for an Antibody–Drug Conjugate 2024 ·The AAPS Journal ·Weifeng Xu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roy Helmy	3
4	An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR‐T and TCR‐T Cellular Therapies Development 2023 ·Clinical Pharmacology & Therapeutics ·Jochem Gokemeijer, (unknown), K. OGASAWARA, (unknown), Vijay Upreti, Hardik Mody, Siddha Kasar, Venkata R. Vepachedu, Weifeng Xu, Swati Gupta, Edit Tarcsa, Robert Dodge, (unknown), Tong‐Yuan Yang, Sophie Tourdot, Vibha Jawa	2
5	A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies 2023 ·The AAPS Journal ·Dilki Wickramarachchi, (unknown), T.Y.C. Woo, Federico Ferrari, (unknown), Roy Helmy, Weifeng Xu	4
6	Phage-Derived Anti-Idiotype and Anti-YTE Antibodies in Development of MK-1654 Pharmacokinetic and Immune Response Assays 2023 ·Bioanalysis ·(unknown), Michael D. Swanson, Nicole Sullivan, (unknown), Debbie Nahas, (unknown), (unknown), Yu Cao, Weifeng Xu, Huaping Tang, Kalpit A. Vora, Zhifeng Chen	2
7	Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial 2022 ·EBioMedicine ·Frédéric Vanhoutte, Wen Liu, Richard T. Wiedmann, (unknown), (unknown), (unknown), Antonios O. Aliprantis, (unknown), Jonathan Hartzel, Jianing Li, (unknown), Katrin Ramsauer, (unknown), Roland Tschismarov, Deborah D. Brown, Weifeng Xu, Jeffrey R. Sachs, Kevin L. Russell, S. Aubrey Stoch, Eseng Lai	18
8	Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis 2022 ·The AAPS Journal ·Weifeng Xu, Brian M. Maas, Brad Roadcap, (unknown), (unknown), Linlin Luo, Marina Ichetovkin, Sandra L. Wood, (unknown), (unknown), Kalpit A. Vora, Roy Helmy	3
9	Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial 2022 ·The Lancet Infectious Diseases ·Heather Platt, (unknown), José F. Cardona, Neil J. Fraser, Richard A. Mularski, Charles M. Andrews, Nizar Daboul, Nancy Gallagher, Aditi Sapre, Jianing Li, Adam B. Polis, Doreen Fernsler, Gretchen Tamms, Weifeng Xu, (unknown), Julie M. Skinner, Joseph G. Joyce, Luwy Musey	52
10	Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing 2018 ·Journal of Immunological Methods ·Weifeng Xu, (unknown), Jennifer Cummings, Stephen M. Carl, (unknown), Carol Gleason, Robert Dodge, Binodh DeSilva, Gerry Kolaitis, Renuka Pillutla	14
11	Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays 2014 ·Journal of Immunological Methods ·Weifeng Xu, Hao Jiang, Craig Titsch, (unknown), Renuka Pillutla, Anne‐Françoise Aubry, Binodh DeSilva, Mark E. Arnold, Jianing Zeng, Robert Dodge	19
12	Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell–stimulating programs in basophils 2009 ·Nature Immunology ·Kang Chen, Weifeng Xu, Melanie Wilson, Bing He, Norman W. Miller, Eva Bengtén, (unknown), Paul A Santini, Poonam Rath, April Chiu, Marco Cattalini, Jiří Litzman, James B. Bussel, Bihui Huang, Jordi Antón, Kristian Riesbeck, Charlotte Cunningham‐Rundles, Alessandro Plebani, Andrea Cerutti	289
13	Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF 2008 ·The Journal of Immunology ·Weifeng Xu, Paul A Santini, Allysia J. Matthews, April Chiu, Alessandro Plebani, Bing He, Kang Chen, Andrea Cerutti	90
14	Epithelial cells trigger frontline immunoglobulin class switching through an SLPI-regulated pathway (41.7) 2007 ·The Journal of Immunology ·Weifeng Xu, Bing He, April Chiu, Amy Chadburn, Meimei Shan, (unknown), Aihao Ding, Daniel M. Knowles, Paul A Santini, Andrea Cerutti	1
15	Intestinal Bacteria Induce T Cell-Independent IgA2 Class Switching by Linking Epithelial Cells with Lamina Propria B Cells through APRIL (40.3) 2007 ·The Journal of Immunology ·Bing He, Weifeng Xu, Paul A Santini, Alexandros D. Polydorides, April Chiu, Amy Chadburn, Daniel M. Knowles, María Rescigno, Andrea Cerutti	1
16	Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL breakdown → 2007 ·Immunity ·Bing He, Weifeng Xu, Paul A Santini, Alexandros D. Polydorides, April Chiu, Jeannelyn S. Estrella, Meimei Shan, Amy Chadburn, Vincenzo Villanacci, Alessandro Plebani, Daniel M. Knowles, María Rescigno, Andrea Cerutti	566
17	Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL 2006 ·Blood ·April Chiu, Weifeng Xu, Bing He, Stacey R. Dillon, Jane A. Gross, Eric L. Sievers, Xugang Qiao, Paul A Santini, Elizabeth Hyjek, (unknown), Ethel Cesarman, Amy Chadburn, Daniel M. Knowles, Andrea Cerutti	157
18	Stat1-Dependent Synergistic Activation of T-bet for IgG2a Production during Early Stage of B Cell Activation 2005 ·The Journal of Immunology ·Weifeng Xu, J. Jillian Zhang	53
19	B Cell Antigen Receptor Signaling Enhances IFN-γ-Induced Stat1 Target Gene Expression Through Calcium Mobilization and Activation of Multiple Serine Kinase Pathways 2005 ·Journal of Interferon & Cytokine Research ·Weifeng Xu, Jayasree S. Nair, Ajay Malhotra, (unknown)	15
20	The Conserved Leu-724 Residue Is Required for Both Serine Phosphorylation and Co-activator Recruitment for Stat1-mediated Transcription Activation in Response to Interferon-γ 2005 ·Journal of Biological Chemistry ·Wei Sun, Weifeng Xu, M Snyder, Wei He, Hao Ho, Lionel B. Ivashkiv, J. Jillian Zhang	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact